LOTTE Fine Chemical Co., Ltd. (KRX:004000)
South Korea · Delayed Price · Currency is KRW 48,050
-1,900 (-3.80%)
At close: Jun 5, 2026
LOTTE Fine Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,817,747 | 1,752,683 | 1,670,545 | 1,768,621 | 2,463,759 | 1,780,293 | |
Revenue Growth (YoY) | 5.89% | 4.92% | -5.54% | -28.21% | 38.39% | 40.89% |
Cost of Revenue | 1,596,332 | 1,547,220 | 1,491,493 | 1,485,694 | 1,938,383 | 1,431,104 |
Gross Profit | 221,415 | 205,463 | 179,052 | 282,927 | 525,376 | 349,189 |
Selling, General & Admin | 99,993 | 98,365 | 97,068 | 99,554 | 97,156 | 82,401 |
Research & Development | 19,938 | 19,764 | 20,197 | 17,194 | 14,616 | 13,182 |
Amortization of Goodwill & Intangibles | 1,646 | 1,642 | 1,573 | 1,636 | 1,866 | 1,857 |
Operating Expenses | 133,168 | 131,018 | 128,679 | 128,149 | 121,065 | 104,603 |
Operating Income | 88,247 | 74,445 | 50,373 | 154,778 | 404,311 | 244,586 |
Interest Expense | -6,215 | -7,802 | -7,140 | -837.24 | -571.38 | -359.35 |
Interest & Investment Income | 31,190 | 33,164 | 42,677 | 56,859 | 13,039 | 1,357 |
Earnings From Equity Investments | 29,572 | 19,573 | 18,809 | 45,372 | 209,357 | 231,947 |
Currency Exchange Gain (Loss) | 2,830 | 3,185 | 1,750 | 909.39 | 175.94 | -2,201 |
Other Non Operating Income (Expenses) | 2,194 | 3,757 | 6,209 | 3,498 | 88,864 | -65,074 |
EBT Excluding Unusual Items | 147,819 | 126,322 | 112,676 | 260,580 | 715,175 | 410,255 |
Gain (Loss) on Sale of Investments | -23.95 | -23.95 | -94,749 | -41,904 | -553,160 | 342,140 |
Gain (Loss) on Sale of Assets | -436.18 | -469.89 | -162.68 | 34,129 | -1,564 | -2,050 |
Asset Writedown | -8,053 | -8,053 | -1,765 | -36.35 | -371.49 | -3,493 |
Pretax Income | 139,305 | 117,775 | 26,052 | 252,768 | 160,080 | 746,852 |
Income Tax Expense | 16,906 | 11,682 | -10,328 | 70,737 | 13,921 | 161,394 |
Earnings From Continuing Operations | 122,399 | 106,093 | 36,381 | 182,032 | 146,159 | 585,458 |
Net Income | 122,399 | 106,093 | 36,381 | 182,032 | 146,159 | 585,458 |
Net Income to Common | 122,399 | 106,093 | 36,381 | 182,032 | 146,159 | 585,458 |
Net Income Growth | - | 191.62% | -80.01% | 24.54% | -75.03% | 194.51% |
Shares Outstanding (Basic) | 25 | 25 | 25 | 25 | 25 | 25 |
Shares Outstanding (Diluted) | 25 | 25 | 25 | 25 | 25 | 25 |
Shares Change (YoY) | -0.02% | - | - | - | - | - |
EPS (Basic) | 4806.34 | 4165.41 | 1428.37 | 7146.90 | 5738.48 | 22986.20 |
EPS (Diluted) | 4806.34 | 4165.41 | 1428.37 | 7146.90 | 5738.48 | 22986.20 |
EPS Growth | - | 191.62% | -80.01% | 24.54% | -75.03% | 194.51% |
Free Cash Flow | 14,870 | 29,316 | -38,081 | 124,154 | 493,456 | 196,695 |
Free Cash Flow Per Share | 583.89 | 1151.02 | -1495.15 | 4874.52 | 19374.01 | 7722.60 |
Dividend Per Share | 1500.000 | 1500.000 | 1400.000 | - | - | - |
Dividend Growth | 7.14% | 7.14% | - | - | - | - |
Gross Margin | 12.18% | 11.72% | 10.72% | 16.00% | 21.32% | 19.61% |
Operating Margin | 4.86% | 4.25% | 3.02% | 8.75% | 16.41% | 13.74% |
Profit Margin | 6.73% | 6.05% | 2.18% | 10.29% | 5.93% | 32.89% |
Free Cash Flow Margin | 0.82% | 1.67% | -2.28% | 7.02% | 20.03% | 11.05% |
EBITDA | 259,030 | 238,812 | 209,722 | 293,341 | 527,954 | 365,423 |
EBITDA Margin | 14.25% | 13.63% | 12.55% | 16.59% | 21.43% | 20.53% |
D&A For EBITDA | 170,782 | 164,367 | 159,350 | 138,562 | 123,643 | 120,837 |
EBIT | 88,247 | 74,445 | 50,373 | 154,778 | 404,311 | 244,586 |
EBIT Margin | 4.86% | 4.25% | 3.02% | 8.75% | 16.41% | 13.74% |
Effective Tax Rate | 12.14% | 9.92% | - | 27.98% | 8.70% | 21.61% |
Advertising Expenses | - | 3,124 | 3,445 | 4,417 | 4,160 | 3,491 |